Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-04-10

Clinical Trial Update: Cefalium® Compared to Tylenol® in the Treatment of Migraine Attacks [Phase 3]

View source ↗

Summary

Phase 3 clinical trial comparing Cefalium® to Tylenol® for migraine treatment has been suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cefalium® (null)
  • Tylenol (acetaminophen)

Snippet

Sponsor: Ache Laboratorios Farmaceuticos S.A. | Conditions: Migraine | Phase 3 | Status: SUSPENDED